Lin Lin

Lin Lin originally joined the group in January 2015, as a coop student from Northeastern University. Lin developed the SAR on the SOD1 and CMT projects. After graduating from Northeastern, Lin is now back at the LDDN and making key contributions to several projects.  In the future, Lin plans to attend medical school.

Allison Leonard recently joined the group as a coop student from Northeastern University.
Priscilla Ogunmola

Priscilla is a student at the University of Huddersfield studying for a MSci in Pharmaceutical Chemistry. Priscilla is spending her placement year here at the LDDN and is focused on the asymmetric synthesis of a number of different heterocycles that increase survival motor neuron protein for the treatment of Spinal Muscular Atrophy.


​Dawid Fiejtek

Dawid originally joined the group in January 2017, as a coop student from Northeastern University.

Dawid is working on the synthesis of analogs in our SMA series that increases transcription of the survival motor neuron protein for the treatment of Spinal Muscular Atrophy.  Dawid is also developing water soluble pro-drugs of a poorly soluble drug that we are re-purposing for AD.  Dawid plans to go to medical school following graduation.

Akbar H. Khan

Akbar grew up in Nepal. He received his MS in Chemistry from Southern Illinois University Edwardsville (SIUE). He worked with Prof. Timothy B. Patrick on method development for the synthesis of fluorinated compounds.  Currently he is working in GlaxoSmithKline (GSK), King of Prussia, PA as Scientist Co-op in Drug Design and Selection (DD&S) Medicinal Chemistry. He is a PhD candidate in Organic Chemistry at Iowa State University and worked on method development and total synthesis of natural products.  He was advised by Professor Jason S. Chen (currently at Scripps, CA). Akbar will join the LDDN in October as a post-doctoral researcher.  In his spare time, Akbar is an amateur photographer.

Matthew Monte recently joined the group as a coop student from Northeastern University.
Jung-Euh (Greg) Ahn will soon be joining the group as a researcher.  Greg is a recent chemistry graduate from Cornell University.
Lisa Montagnon will soon be joining the group as an undergraduate researcher from Bath University UK.
Natasha Riley will soon be joining the group as an undergraduate researcher from York University UK.
Hamilton Coulter will soon be joining the group as an undergraduate researcher from Bath University UK.

Dr. Kevin Hodgetts

Director of ​The Laboratory for Drug Discovery in Neurodegeneration

65 Landsdowne Street 

Cambridge, Massachusetts 02139

U.S.A.


Telephone: 617-768-8640 

Email:  khodgetts@partners.org

 

Contact

Medicinal Chemistry 2016-2017

Dr. Kevin Hodgetts is the Director of LDDN and Head of Medicinal Chemistry.

Kevin has a broad background in organic and medicinal chemistry, with experience in both industrial and academic drug discovery. Kevin spent over 15 years of experience working on treatments for diseases of the central nervous system.  Compounds from two projects that he was involved in have entered clinical trials. Kevin joined the LDDN in September 2012, to work with the academic community to design new and innovative strategies for drug discovery for neurodegenerative diseases. Kevin is Assistant Professor of Neurology at Brigham and Women's Hospital and Harvard Medical School. He also co-founded Klogene Therapeutics with Professor Carmela Abraham.